date,title,source
Oct-29-18,"Minerva Neurosciences to Report Third Quarter 2018 Financial Results and Business Updates on November 5, 2018",GlobeNewswire
Nov-05-18,Edited Transcript of NERV earnings conference call or presentation 5-Nov-18 1:30pm GMT,Thomson Reuters StreetEvents
Nov-05-18,Minerva Neurosciences: 3Q Earnings Snapshot,Associated Press
Nov-05-18,Minerva Neurosciences Reports Third Quarter 2018 Financial Results and Business Updates,GlobeNewswire
Nov-07-18,"Minerva Neurosciences to Present at Jefferies London Healthcare Conference on November 14, 2018",GlobeNewswire
Nov-09-18,"New Research: Key Drivers of Growth for AxoGen, Spirit Realty Capital, e.l.f. Beauty, Minerva Neurosciences, Par Pacific, and Calithera Biosciences  Factors of Influence, Major Initiatives and Sustained Production",GlobeNewswire
Nov-15-18,"Minerva Neurosciences to Host Roluperidone Update and Key Opinion Leader Discussion of Negative Symptoms in CNS/Psychiatric Diseases on November 20, 2018",GlobeNewswire
Nov-16-18,Minerva Neurosciences Sees Hammer Chart Pattern: Time to Buy?,Zacks
Nov-19-18,Minerva Neurosciences Announces Results of Dose Escalation Study Evaluating Roluperidone (MIN-101) Administered at Supra-Therapeutic Doses in Healthy Volunteers,GlobeNewswire
